Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Infection and Immunity|September 14, 2011
A small molecule deubiquitinase inhibitor increases localization of inducible nitric oxide synthase to the macrophage phagosome and enhances bacterial killingKristin M Burkholder, Jeffrey W Perry, Christiane E Wobus, et al.
Anti-Cancer Drug Design|August 1, 1994
Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activityD W Fry, A J Kraker, R C Connors, et al.
Animal Genetics|December 12, 2001
Identification of porcine Lhx3 and SF1 as candidate genes for QTL affecting growth and reproduction traits in swineT P Smith, A D Showalter, K W Sloop, et al.
Drug Design and Discovery|January 1, 1993
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitroM A Naylor, M D Threadgill, H D Showalter, et al.
Neurology|June 6, 2007
Worsening of quality of life after epilepsy surgery: effect of seizures and memory declineJ T Langfitt, M Westerveld, M J Hamberger, et al.
Cellular Signalling|August 23, 2011
A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitinationVaibhav Kapuria, Alexander Levitzki, William G Bornmann, et al.
Molecular Pharmacology|August 8, 2018
Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKKε and Reveal Mechanisms for Selective InhibitionTyler S Beyett, Xinmin Gan, Shannon M Reilly, et al.
Plos One|April 12, 2014
Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA virusesMarta J Gonzalez-Hernandez, Anupama Pal, Kofi E Gyan, et al.
The Journal of Antibiotics|December 1, 1992
Improved production of pentostatin and identification of fermentation cometabolitesH D Showalter, R H Bunge, J C French, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2017
Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing EffectsColleen Carpenter, Alexander G Zestos, Rachel Altshuler, et al.
Pageof 22